Tag: <span>weight loss</span>

Health Studies

Semaglutide Tied to 40% Fewer Asthma Attacks and 20% Fewer COPD Flare-Ups in Landmark Real-World Study

People with asthma and chronic obstructive pulmonary disease (COPD) who take the GLP-1 receptor agonist semaglutide appear to suffer significantly fewer acute respiratory attacks, according...

Breakthroughs

Natural Ozempic Molecule BRP Discovered by Stanford Scientists Using AI — No Nausea or Muscle Loss

Stanford Medicine researchers have identified a naturally occurring molecule that mimics the appetite-suppressing power of semaglutide — the active ingredient in Ozempic — without the...

Medications & Treatments

Medicare Now Covers GLP-1 Weight Loss Drugs: What Seniors Need to Know About the $50 Monthly Copay

Millions of Seniors Gain Access to Affordable Weight-Loss Medications In a historic shift in public health policy, Medicare has officially begun covering GLP-1 weight-loss drugs...

Breast Health

GLP-1 Drugs Like Ozempic and Wegovy Linked to 30% Lower Breast Cancer Risk, Major Study Finds

A major new study involving more than 110,000 women has found that popular GLP-1 weight-loss and diabetes drugs — including Ozempic, Wegovy, Mounjaro, and Zepbound...